We are live on ! Find out more
AP

Andera Partners Portfolio holdings

AUM $176M Turnover 12.5%
1-Year Est. Return 1.8%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+1.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$30.8M
Cap. Flow
-$25.9M
Cap. Flow %
-14.76%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Avg Time Held
0.6 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EVMN icon
Evommune Inc
EVMN
+$15.5M
2
ABVX icon
Abivax
ABVX
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KMTS icon
1
Kestra Medical Technologies
KMTS
$1.75B
$77.2M 43.94%
2,728,679
– –
2025 Q4
3 quarters
MLYS icon
2
Mineralys Therapeutics
MLYS
$1.85B
$40M 22.77%
1,591,917
– –
2025 Q4
3 quarters
AVLN icon
3
Avalyn Pharma
AVLN
$1.03B
$26.5M 15.08%
929,824
– –
2026 Q2
1 quarter
AGMB icon
4
AgomAb Therapeutics NV
AGMB
$405M
$17.1M 9.72%
1,538,702
– –
2026 Q1
2 quarters
IVA icon
5
Inventiva
IVA
$704M
$13.4M 7.63%
3,633,181
– –
2025 Q4
3 quarters
EVMN icon
6
Evommune Inc
EVMN
$191M
$804K 0.46%
97,362
-1,294,628
-93% -$15.5M
2025 Q4
3 quarters
NYXH icon
7
Nyxoah
NYXH
$97.2M
$720K 0.41%
522,057
– –
2026 Q1
2 quarters
ABVX icon
8
Abivax
ABVX
$7.64B
– –
-78,125
Closed -$10.4M –

Similar funds

MDP
Millbank Dartmoor Portsmouth Asheville, North Carolina $176M AUM
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
RFW
Rainier Family Wealth Tacoma, Washington $176M AUM 26.86% 1-Year Est. Return
SLWM
Stone Loft Wealth Management West Chester, Pennsylvania $176M AUM
PC
Pelham Capital London, United Kingdom $176M AUM 37.46% 1-Year Est. Return
PFA
Providence Financial Advisors Overland Park, Kansas $176M AUM 23.64% 1-Year Est. Return
MP
Marcho Partners London, United Kingdom $176M AUM 7.16% 1-Year Est. Return
FFS
Flavin Financial Services Melbourne, Florida $175M AUM 17.14% 1-Year Est. Return

Andera Partners's Q3 2026 Portfolio in Review

As of Q3 2026, Andera Partners held 8 positions worth $176M, down 15% from $206M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Andera Partners withdrew a net $25.9M in Q3 2026, closing 1 position and reducing 1 holding. Its most notable exit was Abivax, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Andera Partners's biggest Q3 2026 reduction was Evommune Inc, cutting an estimated $15.5M.
  • Andera Partners fully exited Abivax in Q3 2026, selling an estimated $10.4M.
  • Andera Partners's ten largest holdings make up 100% of its $176M portfolio in Q3 2026.
  • Andera Partners opened 0 new positions and closed 1 in Q3 2026.
  • Andera Partners's portfolio value fell 15% quarter-over-quarter to $176M.

Based on Andera Partners's 13F filing for Q3 2026, filed 16 Oct 2026.